Based on SHetA2 disruption of mortalin complexes and the essential roles of mortalin in import of nuclear encoded proteins into, and maintenance of, mitochondria [50], we predicted that SHetA2 would cause mitochondrial damage and altered metabolism in endometrial cancer cells. The gene discussed is HSPA9; the disease is endometrial cancer.